| The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review RE Vickman, OE Franco, DC Moline, DJ Vander Griend, P Thumbikat, ... Asian journal of urology 7 (3), 191-202, 2020 | 140 | 2020 |
| Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the Wnt/β-catenin pathway HJ Lee, J Li, RE Vickman, J Li, R Liu, AC Durkes, BD Elzey, S Yue, X Liu, ... Molecular Cancer Research 16 (6), 974-985, 2018 | 76 | 2018 |
| Heterogeneity of human prostate carcinoma‐associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment RE Vickman, MM Broman, NA Lanman, OE Franco, PAG Sudyanti, Y Ni, ... The Prostate 80 (2), 173-185, 2020 | 65 | 2020 |
| Folate receptor beta designates immunosuppressive tumor-associated myeloid cells that can be reprogrammed with folate-targeted drugs GM Cresswell, B Wang, EM Kischuk, MM Broman, RA Alfar, RE Vickman, ... Cancer research 81 (3), 671-684, 2021 | 57 | 2021 |
| DGAT1 inhibitor suppresses prostate tumor growth and migration by regulating intracellular lipids and non-centrosomal MTOC protein GM130 F Nardi, OE Franco, P Fitchev, A Morales, RE Vickman, SW Hayward, ... Scientific reports 9 (1), 3035, 2019 | 46 | 2019 |
| TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease RE Vickman, LT Aaron-Brooks, R Zhang, NA Lanman, B Lapin, V Gil, ... Nature communications 13 (1), 2133, 2022 | 45 | 2022 |
| Cholesterol sulfonation enzyme, SULT2B1b, modulates AR and cell growth properties in prostate cancer RE Vickman, SA Crist, K Kerian, L Eberlin, RG Cooks, GN Burcham, ... Molecular Cancer Research 14 (9), 776-786, 2016 | 40 | 2016 |
| Deconstructing tumor heterogeneity: the stromal perspective RE Vickman, DV Faget, P Beachy, D Beebe, NA Bhowmick, E Cukierman, ... Oncotarget 11 (40), 3621, 2020 | 38 | 2020 |
| Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation KM Goode, DP Petrov, RE Vickman, SA Crist, PE Pascuzzi, TL Ratliff, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (8), 1992-2006, 2017 | 35 | 2017 |
| Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse LTM Aaron‐Brooks, T Sasaki, RE Vickman, L Wei, OE Franco, Y Ji, ... The Prostate 79 (9), 980-993, 2019 | 23 | 2019 |
| Fibroblast heterogeneity in prostate carcinogenesis S ChallaSivaKanaka, RE Vickman, M Kakarla, SW Hayward, OE Franco Cancer letters 525, 76-83, 2022 | 19 | 2022 |
| Ephrin B activate Src family kinases in fibroblasts inducing stromal remodeling in prostate cancer M Kakarla, S ChallaSivaKanaka, MF Dufficy, V Gil, Y Filipovich, ... Cancers 14 (9), 2336, 2022 | 12 | 2022 |
| Cholesterol sulfotransferase SULT2B1b modulates sensitivity to death receptor ligand TNFα in castration-resistant prostate cancer RE Vickman, J Yang, NA Lanman, GM Cresswell, F Zheng, C Zhang, ... Molecular Cancer Research 17 (6), 1253-1263, 2019 | 12 | 2019 |
| Shared inherited genetics of benign prostatic hyperplasia and prostate cancer A Glaser, Z Shi, J Wei, NA Lanman, S Ladson-Gary, RE Vickman, ... European urology open science 43, 54-61, 2022 | 9 | 2022 |
| Contributions of carcinoma-associated fibroblasts to the prostate cancer microenvironment RE Vickman, OE Franco, SW Hayward Current Opinion in Endocrine and Metabolic Research 10, 1-6, 2020 | 3 | 2020 |
| Could TNF-antagonists be a novel treatment strategy for BPH patients? RE Vickman, OE Franco, SW Hayward Cell Stress 6 (6), 65, 2022 | 2 | 2022 |
| Characterization of prostate macrophage heterogeneity, foam cell markers, and CXCL17 upregulation in a mouse model of steroid hormone imbalance SV Silver, KJ Tucker, RE Vickman, NA Lanman, OJ Semmes, NS Alvarez, ... Scientific Reports 14 (1), 21029, 2024 | | 2024 |
| PROSTATE CELL HETEROGENEITY AND CXCL17 UPREGULATION IN MOUSE STEROID HORMONE IMBALANCE SV Silver, KJ Tucker, RE Vickman, NA Lanman, OJ Semmes, NS Alvarez, ... bioRxiv, 2024 | | 2024 |
| The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model SC Shin, RE Vickman, B Filimon, Y Yang, Z Hu, KA Mangold, ... Cancer Gene Therapy 31 (4), 574-585, 2024 | | 2024 |
| Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia NA Lanman, E Meco, P Fitchev, AK Kolliegbo, MM Broman, Y Filipovich, ... bioRxiv, 2024.06. 07.597992, 2024 | | 2024 |
